| Application no. and date | 12711500.4 (espacenet) (Federated) (European Patent Register), 20120309 | | Patent/reg. no. and date | DK/EP 2683385, 20180606 | | Publication date | 20140115 | | Priority no. and date | US 201161451531 P, 20110310 | | EP pub. no. and date |
EP 2683385 20140115 | | Effective date | | | Applicant/owner | Rigel Pharmaceuticals, Inc., 1180 Veterans Boulevard
South San Francisco, CA 94080, US | | Applicant ref. no. | RIG EP2683385 | | Inventor | MAGILAVY, Daniel, 1933 Laguna Street
San Francisco, CA 94115, US,
PINE, Polly, 786 Partridge Ave.
Menlo Park, CA 94025, US | | Representative | RWS Group, Europa House
Chiltern Park, Chiltern Hill
Chalfont St Peter
Bucks SL9 9FG, GB | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61P 17/00 (2006.01) | | Title | 2,4-SUBSTITUEREDE PYRIMIDINDIAMINER TIL ANVENDELSE VED DISKOID LUPUS | | Int. application no. | US2012028429 | | Int. publication no. | WO2012122452 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
